106. クリオピリン関連周期熱症候群 Cryopyrin-associated periodic syndrome Clinical trials / Disease details

臨床試験数 : 42 / 薬物数 : 24 - (DrugBank : 4) / 標的遺伝子数 : 4 - 標的パスウェイ数 : 48

diseases per page:

Showing 1 to 10 of 42 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04868968 (ClinicalTrials.gov)	September 20, 2021	22/4/2021	Study of Safety, Tolerability and Efficacy of DFV890 in Participants With Familial Cold Auto-inflamm ...	An Open-label, Single Arm Phase II Study of DFV890 to Assess the Safety, Tolerability and Efficacy i ...	Familial Cold Autoinflammatory Syndrome	Drug: DFV890	Novartis Pharmaceuticals	NULL	Recruiting	18 Years	80 Years	All	6	Phase 2	United States;France;Germany;Italy
2	EUCTR2020-005948-33-DE (EUCTR)	26/07/2021	26/02/2021	Study of safety, tolerability and efficacy of DFV890 in participants with familial cold auto-inflamm ...	An open-label, single arm phase II study of DFV890 to assess the safety, tolerability and efficacy i ...	Familial Cold Autoinflammatory Syndrome(FCAS) MedDRA version: 20.0;Level: PT;Classification code 100 ...	Product Name: DFV890 Product Code: DFV890 INN or Proposed INN: Not yet established	Novartis Pharma AG	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	6	Phase 2	United States;Germany;Italy
3	EUCTR2020-005948-33-IT (EUCTR)	07/06/2021	08/06/2021	Study of safety, tolerability and efficacy of DFV890 in participants with familial cold auto-inflamm ...	An open-label, single arm phase II study of DFV890 to assess the safety, tolerability and efficacy i ...	Familial Cold Autoinflammatory Syndrome(FCAS). MedDRA version: 20.0;Level: PT;Classification code 10 ...	Product Name: - Product Code: [DFV890]	NOVARTIS PHARMA AG	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	6	Phase 1;Phase 2	United States;Germany;Italy
4	NCT04524858 (ClinicalTrials.gov)	October 23, 2020	19/8/2020	Study of ATI-450 in Patients With Cryopyrin-Associated Periodic Syndrome (CAPS)	A Phase 2a, Open-Label, Single-Arm Study to Investigate the Safety and Efficacy of ATI-450 for the M ...	Cryopyrin-Associated Periodic Syndrome	Drug: ATI-450	Aclaris Therapeutics, Inc.	NULL	Terminated	18 Years	N/A	All	1	Phase 2	United States
5	EUCTR2020-000489-40-GB (EUCTR)	22/09/2020	03/04/2020	A Phase IIb study to Evaluate the Safety, Tolerability and Efficacy of IZD174 in Patients with Cryop ...	A Multi-Centre, Randomised, Open-Label, Phase IIb Study to Evaluate the Safety, Tolerability and Eff ...	Cryopyrin-associated periodic syndrome(CAPS) MedDRA version: 20.0;Level: PT;Classification code 1006 ...	Product Name: IZD174 Product Code: C-028380 INN or Proposed INN: N/A Other descriptive name: Inzomelid P ...	Inflazome (Australia) Pty Ltd.	NULL	Not Recruiting			Female: yes Male: yes	14	Phase 2	Ireland;Australia;United Kingdom
6	NCT04086602 (ClinicalTrials.gov)	September 13, 2019	9/9/2019	Safety and Tolerability, Pharmacokinetic and Pharmacodynamic Study With IZD334	A Phase 1, Randomised, Double-Blind, Placebo-Controlled, Single and Multiple Ascending Dose Study to ...	Healthy Volunteers;Cryopyrin Associated Periodic Syndrome	Drug: IZD334;Drug: Placebos	Inflazome UK Ltd	NULL	Completed	18 Years	65 Years	All	64	Phase 1	Australia
7	NCT03923140 (ClinicalTrials.gov)	May 23, 2019	14/4/2019	A Clinical Study of Tranilast in the Treatment of Cryopyrin-Associated Periodic Syndrome (CAPS)	Efficacy and Safety of Tranilast in Patients With Cryopyrin-Associated Periodic Syndrome(CAPS): A Si ...	Cryopyrin-Associated Periodic Syndromes	Drug: Tranilast	Peking Union Medical College Hospital	NULL	Recruiting	N/A	N/A	All	71	Phase 2	China
8	EUCTR2014-001393-34-BE (EUCTR)	14/04/2014	03/04/2014	Ilaris® (canakinumab) efficacy and safety in CAPS patients without confirmed mutation on exon 3 of g ...	Ilaris® (canakinumab) efficacy and safety in CAPS patients without confirmed mutation on exon 3 of g ...	Cryopyrin-Associated Periodic Syndromes MedDRA version: 17.1;Level: PT;Classification code 10068850; ...	Trade Name: Ilaris Product Name: Ilaris	UZ Leuven	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes			Belgium
9	EUCTR2011-005154-57-GB (EUCTR)	09/03/2013	13/11/2013	A study to check how safe, beneficial and tolerable the drug canakinumab, along with childhood vacci ...	An open-label extension study to assess efficacy, safety and tolerability of canakinumab and the eff ...	Cryopyrin Associated Periodic Syndromes (CAPS) MedDRA version: 17.0;Level: PT;Classification code 10 ...	Product Name: canakinumab Product Code: ACZ885 INN or Proposed INN: CANAKINUMAB	Novartis Pharma Services AG	NULL	Not Recruiting			Female: yes Male: yes	16	Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): no Therapeutic confirmatory - (P ...	France;Canada;Belgium;Spain;Israel;Germany;United Kingdom
10	EUCTR2011-005154-57-FR (EUCTR)	08/02/2013	19/01/2012	A study to check how safe, beneficial and tolerable the drug canakinumab, along with childhood vacci ...	An open-label extension study to assess efficacy, safety and tolerability of canakinumab and the eff ...	Cryopyrin Associated Periodic Syndromes (CAPS) MedDRA version: 14.1;Level: PT;Classification code 10 ...	Trade Name: ILARIS Product Name: canakinumab Product Code: ACZ885 INN or Proposed INN: CANAKINUMAB	Novartis Pharma Services AG	NULL	Not Recruiting			Female: yes Male: yes	16		France;Canada;Belgium;Spain;Israel;Germany;United Kingdom

First Previous1 2 3 4 5Next Last